Global Human Microbiome Therapeutics Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
SKU ID :GIR-13717876 | Published Date: 11-Jan-2019 | No. of pages: 117Description
TOC
Table of Contents
1 Human Microbiome Therapeutics Market Overview
1.1 Product Overview and Scope of Human Microbiome Therapeutics
1.2 Classification of Human Microbiome Therapeutics by Types
1.2.1 Global Human Microbiome Therapeutics Revenue Comparison by Types (2017-2023)
1.2.2 Global Human Microbiome Therapeutics Revenue Market Share by Types in 2017
1.2.3 FMT
1.2.4 Microbiome Drugs
1.3 Global Human Microbiome Therapeutics Market by Application
1.3.1 Global Human Microbiome Therapeutics Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 C. difficile
1.3.3 Crohn’s Disease
1.3.4 Inflammatory Bowel Disease
1.3.5 Diabetes
1.3.6 Others
1.4 Global Human Microbiome Therapeutics Market by Regions
1.4.1 Global Human Microbiome Therapeutics Market Size (Million The) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Human Microbiome Therapeutics Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Human Microbiome Therapeutics Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Human Microbiome Therapeutics Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Human Microbiome Therapeutics Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Human Microbiome Therapeutics Status and Prospect (2013-2023)
1.5 Global Market Size of Human Microbiome Therapeutics (2013-2023)
2 Manufacturers Profiles
2.1 Enterome Bioscience
2.1.1 Business Overview
2.1.2 Human Microbiome Therapeutics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Enterome Bioscience Human Microbiome Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.2 Rebiotix
2.2.1 Business Overview
2.2.2 Human Microbiome Therapeutics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Rebiotix Human Microbiome Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.3 Seres Therapeutics
2.3.1 Business Overview
2.3.2 Human Microbiome Therapeutics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Seres Therapeutics Human Microbiome Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.4 Vedanta Biosciences
2.4.1 Business Overview
2.4.2 Human Microbiome Therapeutics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Vedanta Biosciences Human Microbiome Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.5 Bristol-Myers Squibb
2.5.1 Business Overview
2.5.2 Human Microbiome Therapeutics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Bristol-Myers Squibb Human Microbiome Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.6 Johnson & Johnson
2.6.1 Business Overview
2.6.2 Human Microbiome Therapeutics Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Johnson & Johnson Human Microbiome Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.7 Takeda Pharmaceutical
2.7.1 Business Overview
2.7.2 Human Microbiome Therapeutics Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Takeda Pharmaceutical Human Microbiome Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
3 Global Human Microbiome Therapeutics Market Competition, by Players
3.1 Global Human Microbiome Therapeutics Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Human Microbiome Therapeutics Players Market Share
3.2.2 Top 10 Human Microbiome Therapeutics Players Market Share
3.3 Market Competition Trend
4 Global Human Microbiome Therapeutics Market Size by Regions
4.1 Global Human Microbiome Therapeutics Revenue and Market Share by Regions
4.2 North America Human Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
4.3 Europe Human Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Human Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
4.5 South America Human Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Human Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
5 North America Human Microbiome Therapeutics Revenue by Countries
5.1 North America Human Microbiome Therapeutics Revenue by Countries (2013-2018)
5.2 USA Human Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
5.3 Canada Human Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
5.4 Mexico Human Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
6 Europe Human Microbiome Therapeutics Revenue by Countries
6.1 Europe Human Microbiome Therapeutics Revenue by Countries (2013-2018)
6.2 Germany Human Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
6.3 UK Human Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
6.4 France Human Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
6.5 Russia Human Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
6.6 Italy Human Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Human Microbiome Therapeutics Revenue by Countries
7.1 Asia-Pacific Human Microbiome Therapeutics Revenue by Countries (2013-2018)
7.2 China Human Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
7.3 Japan Human Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
7.4 Korea Human Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
7.5 India Human Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Human Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
8 South America Human Microbiome Therapeutics Revenue by Countries
8.1 South America Human Microbiome Therapeutics Revenue by Countries (2013-2018)
8.2 Brazil Human Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
8.3 Argentina Human Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
8.4 Colombia Human Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Human Microbiome Therapeutics by Countries
9.1 Middle East and Africa Human Microbiome Therapeutics Revenue by Countries (2013-2018)
9.2 Saudi Arabia Human Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
9.3 UAE Human Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
9.4 Egypt Human Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
9.5 Nigeria Human Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
9.6 South Africa Human Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
10 Global Human Microbiome Therapeutics Market Segment by Type
10.1 Global Human Microbiome Therapeutics Revenue and Market Share by Type (2013-2018)
10.2 Global Human Microbiome Therapeutics Market Forecast by Type (2018-2023)
10.3 FMT Revenue Growth Rate (2013-2023)
10.4 Microbiome Drugs Revenue Growth Rate (2013-2023)
11 Global Human Microbiome Therapeutics Market Segment by Application
11.1 Global Human Microbiome Therapeutics Revenue Market Share by Application (2013-2018)
11.2 Human Microbiome Therapeutics Market Forecast by Application (2018-2023)
11.3 C. difficile Revenue Growth (2013-2018)
11.4 Crohn’s Disease Revenue Growth (2013-2018)
11.5 Inflammatory Bowel Disease Revenue Growth (2013-2018)
11.6 Diabetes Revenue Growth (2013-2018)
11.7 Others Revenue Growth (2013-2018)
12 Global Human Microbiome Therapeutics Market Size Forecast (2018-2023)
12.1 Global Human Microbiome Therapeutics Market Size Forecast (2018-2023)
12.2 Global Human Microbiome Therapeutics Market Forecast by Regions (2018-2023)
12.3 North America Human Microbiome Therapeutics Revenue Market Forecast (2018-2023)
12.4 Europe Human Microbiome Therapeutics Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Human Microbiome Therapeutics Revenue Market Forecast (2018-2023)
12.6 South America Human Microbiome Therapeutics Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Human Microbiome Therapeutics Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Tables & Figures
List of Tables and Figures
Figure Human Microbiome Therapeutics Picture
Table Product Specifications of Human Microbiome Therapeutics
Table Global Human Microbiome Therapeutics and Revenue (Million The) Market Split by Product Type
Figure Global Human Microbiome Therapeutics Revenue Market Share by Types in 2017
Figure FMT Picture
Figure Microbiome Drugs Picture
Table Global Human Microbiome Therapeutics Revenue (Million The) by Application (2013-2023)
Figure Human Microbiome Therapeutics Revenue Market Share by Applications in 2017
Figure C. difficile Picture
Figure Crohn’s Disease Picture
Figure Inflammatory Bowel Disease Picture
Figure Diabetes Picture
Figure Others Picture
Table Global Market Human Microbiome Therapeutics Revenue (Million The) Comparison by Regions 2013-2023
Figure North America Human Microbiome Therapeutics Revenue (Million The) and Growth Rate (2013-2023)
Figure Europe Human Microbiome Therapeutics Revenue (Million The) and Growth Rate (2013-2023)
Figure Asia-Pacific Human Microbiome Therapeutics Revenue (Million The) and Growth Rate (2013-2023)
Figure South America Human Microbiome Therapeutics Revenue (Million The) and Growth Rate (2013-2023)
Figure Middle East and Africa Human Microbiome Therapeutics Revenue (Million The) and Growth Rate (2013-2023)
Figure Global Human Microbiome Therapeutics Revenue (Million The) and Growth Rate (2013-2023)
Table Enterome Bioscience Basic Information, Manufacturing Base and Competitors
Table Enterome Bioscience Human Microbiome Therapeutics Type and Applications
Table Enterome Bioscience Human Microbiome Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Rebiotix Basic Information, Manufacturing Base and Competitors
Table Rebiotix Human Microbiome Therapeutics Type and Applications
Table Rebiotix Human Microbiome Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Seres Therapeutics Basic Information, Manufacturing Base and Competitors
Table Seres Therapeutics Human Microbiome Therapeutics Type and Applications
Table Seres Therapeutics Human Microbiome Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Vedanta Biosciences Basic Information, Manufacturing Base and Competitors
Table Vedanta Biosciences Human Microbiome Therapeutics Type and Applications
Table Vedanta Biosciences Human Microbiome Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Human Microbiome Therapeutics Type and Applications
Table Bristol-Myers Squibb Human Microbiome Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Human Microbiome Therapeutics Type and Applications
Table Johnson & Johnson Human Microbiome Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Takeda Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Takeda Pharmaceutical Human Microbiome Therapeutics Type and Applications
Table Takeda Pharmaceutical Human Microbiome Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Global Human Microbiome Therapeutics Revenue (Million The) by Players (2013-2018)
Table Global Human Microbiome Therapeutics Revenue Share by Players (2013-2018)
Figure Global Human Microbiome Therapeutics Revenue Share by Players in 2016
Figure Global Human Microbiome Therapeutics Revenue Share by Players in 2017
Figure Global Top 5 Players Human Microbiome Therapeutics Revenue Market Share in 2017
Figure Global Top 10 Players Human Microbiome Therapeutics Revenue Market Share in 2017
Figure Global Human Microbiome Therapeutics Revenue (Million The) and Growth Rate (%) (2013-2018)
Table Global Human Microbiome Therapeutics Revenue (Million The) by Regions (2013-2018)
Table Global Human Microbiome Therapeutics Revenue Market Share by Regions (2013-2018)
Figure Global Human Microbiome Therapeutics Revenue Market Share by Regions (2013-2018)
Figure Global Human Microbiome Therapeutics Revenue Market Share by Regions in 2017
Figure North America Human Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Figure Europe Human Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Human Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Figure South America Human Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Human Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Table North America Human Microbiome Therapeutics Revenue by Countries (2013-2018)
Table North America Human Microbiome Therapeutics Revenue Market Share by Countries (2013-2018)
Figure North America Human Microbiome Therapeutics Revenue Market Share by Countries (2013-2018)
Figure North America Human Microbiome Therapeutics Revenue Market Share by Countries in 2017
Figure USA Human Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Figure Canada Human Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Figure Mexico Human Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Table Europe Human Microbiome Therapeutics Revenue (Million The) by Countries (2013-2018)
Figure Europe Human Microbiome Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Europe Human Microbiome Therapeutics Revenue Market Share by Countries in 2017
Figure Germany Human Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Figure UK Human Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Figure France Human Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Figure Russia Human Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Figure Italy Human Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Human Microbiome Therapeutics Revenue (Million The) by Countries (2013-2018)
Figure Asia-Pacific Human Microbiome Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Human Microbiome Therapeutics Revenue Market Share by Countries in 2017
Figure China Human Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Figure Japan Human Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Figure Korea Human Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Figure India Human Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Human Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Table South America Human Microbiome Therapeutics Revenue by Countries (2013-2018)
Table South America Human Microbiome Therapeutics Revenue Market Share by Countries (2013-2018)
Figure South America Human Microbiome Therapeutics Revenue Market Share by Countries (2013-2018)
Figure South America Human Microbiome Therapeutics Revenue Market Share by Countries in 2017
Figure Brazil Human Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Figure Argentina Human Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Figure Colombia Human Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Human Microbiome Therapeutics Revenue (Million The) by Countries (2013-2018)
Table Middle East and Africa Human Microbiome Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Human Microbiome Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Human Microbiome Therapeutics Revenue Market Share by Countries in 2017
Figure Saudi Arabia Human Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Figure UAE Human Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Figure Egypt Human Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Figure Nigeria Human Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Figure South Africa Human Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Table Global Human Microbiome Therapeutics Revenue (Million The) by Type (2013-2018)
Table Global Human Microbiome Therapeutics Revenue Share by Type (2013-2018)
Figure Global Human Microbiome Therapeutics Revenue Share by Type (2013-2018)
Figure Global Human Microbiome Therapeutics Revenue Share by Type in 2017
Table Global Human Microbiome Therapeutics Revenue Forecast by Type (2018-2023)
Figure Global Human Microbiome Therapeutics Market Share Forecast by Type (2018-2023)
Figure Global FMT Revenue Growth Rate (2013-2018)
Figure Global Microbiome Drugs Revenue Growth Rate (2013-2018)
Table Global Human Microbiome Therapeutics Revenue by Application (2013-2018)
Table Global Human Microbiome Therapeutics Revenue Share by Application (2013-2018)
Figure Global Human Microbiome Therapeutics Revenue Share by Application (2013-2018)
Figure Global Human Microbiome Therapeutics Revenue Share by Application in 2017
Table Global Human Microbiome Therapeutics Revenue Forecast by Application (2018-2023)
Figure Global Human Microbiome Therapeutics Market Share Forecast by Application (2018-2023)
Figure Global C. difficile Revenue Growth Rate (2013-2018)
Figure Global Crohn’s Disease Revenue Growth Rate (2013-2018)
Figure Global Inflammatory Bowel Disease Revenue Growth Rate (2013-2018)
Figure Global Diabetes Revenue Growth Rate (2013-2018)
Figure Global Others Revenue Growth Rate (2013-2018)
Figure Global Human Microbiome Therapeutics Revenue (Million The) and Growth Rate Forecast (2018 -2023)
Table Global Human Microbiome Therapeutics Revenue (Million The) Forecast by Regions (2018-2023)
Figure Global Human Microbiome Therapeutics Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Human Microbiome Therapeutics Revenue Market Forecast (2018-2023)
Figure Europe Human Microbiome Therapeutics Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Human Microbiome Therapeutics Revenue Market Forecast (2018-2023)
Figure South America Human Microbiome Therapeutics Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Human Microbiome Therapeutics Revenue Market Forecast (2018-2023)
Companies
Enterome Bioscience
Rebiotix
Seres Therapeutics
Vedanta Biosciences
Bristol-Myers Squibb
Johnson & Johnson
Takeda Pharmaceutical
- PRICE
-
$3480$6960$5220Buy Now